Protective effect of erythropoietin against ketamine-induced apoptosis in cultured rat cortical neurons: Involvement of PI3K/Akt and GSK-3 beta pathway

Apoptosis

Volumn 12, Issue 12, 2007, Pages 2187-2195

  Shang, You ^a   Wu, Yan ^a   Yao, Shanglong ^a   Wang, Xiaojing ^b,c   Feng, Dan ^a   Yang, Wenqiong ^d  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c XUZHOU MEDICAL UNIVERSITY   (China)

^d Dongfeng Hospital   (China)

Author keywords

Akt; Caspase 3; Cortical neurons; Erythropoietin; GSK 3 ; Ketamine; Neuroprotection

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CASPASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; KETAMINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RECOMBINANT ERYTHROPOIETIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN CORTEX; CELL VIABILITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; IMMUNOBLOTTING; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; CASPASE 3; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CHROMONES; DOWN-REGULATION; ERYTHROPOIETIN; GLYCOGEN SYNTHASE KINASE 3; HUMANS; KETAMINE; MORPHOLINES; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS;

RATTUS;

EID: 35948937561     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-007-0141-1     Document Type: Article

References (33)

1. Hayashi H, Dikkes P, Soriano SG (2002) Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain. Paediatr Anaesth 12:770-774
2. Rudin M, Ben-Abraham R, Gazit V, Tendler Y, Tashlykov V, Katz Y (2005) Single-dose ketamine administration induces apoptosis in neonatal mouse brain. J Basic Clin Physiol Pharmacol 16:231-243
3. Slikker W, Zou X, Hotchkiss CE et al (2007) Ketamine-induced neuronal cell death in the perinatal rhesus monkey. Toxicol Sci 98:145-158
4. Wang C, Sadovova N, Hotchkiss C et al (2006) Blockade of N-methyl-D-aspartate receptors by ketamine produces loss of postnatal day 3 monkey frontal cortical neurons in culture. Toxicol Sci 91:192-201
5. Young C, Jevtovic-Todorovic V, Qin YQ et al (2005) Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain. Br J Pharmacol 146:189-197
6. Takadera T, Ishida A, Ohyashiki T (2006) Ketamine-induced apoptosis in cultured rat cortical neurons. Toxicol Appl Pharmacol 210:100-107
7. Wang C, Sadovova N, Fu X et al (2005) The role of the N-methyl-D-aspartate receptor in ketamine-induced apoptosis in rat forebrain culture. Neuroscience 132:967-977
8. Willis CL, Ray DE (2007) Antioxidants attenuate MK-801-induced cortical neurotoxicity in the rat. Neurotoxicology 28:161-167
9. Jevtovic-Todorovic V, Wozniak DF, Powell S, Olney JW (2001) Propofol and sodium thiopental protect against MK-801-induced neuronal necrosis in the posterior cingulate/retrosplenial cortex. Brain Res 913:185-189
10. Takadera T, Matsuda I, Ohyashiki T (1999) Apoptotic cell death and caspase-3 activation induced by N-methyl-D-aspartate receptor antagonists and their prevention by insulin-like growth factor I. J Neurochem 73:548-556
11. Jelkmann W, Pagel H, Wolff M, Fandrey J (1992) Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci 50:301-308
12. Ehrenreich H, Aust C, Krampe H et al (2004) Erythropoietin: novel approaches to neuroprotection in human brain disease. Metab Brain Dis 19:195-206
13. Hasselblatt M, Ehrenreich H, Siren AL (2006) The brain erythropoietin system and its potential for therapeutic exploitation in brain disease. J Neurosurg Anesthesiol 18:132-138
14. Dzietko M, Felderhoff-Mueser U, Sifringer M et al (2004) Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity. Neurobiol Dis 15:177-187
15. Digicaylioglu M, Bichet S, Marti HH et al (1995) Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci USA 92:3717-3720
16. Juul SE, Anderson DK, Li Y, Christensen RD (1998) Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr Res 43:40-49
17. Juul SE, Yachnis AT, Rojiani AM, Christensen RD (1999) Immunohistochemical localization of erythropoietin and its receptor in the developing human brain. Pediatr Dev Pathol 2:148-158
18. Liu C, Shen K, Liu Z, Noguchi CT (1997) Regulated human erythropoietin receptor expression in mouse brain. J Biol Chem 272:32395-32400
19. Mellon RD, Simone AF, Rappaport BA (2007) Use of anesthetic agents in neonates and young children. Anesth Analg 104:509-520
20. Scallet AC, Schmued LC, Slikker W et al (2004) Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons. Toxicol Sci 81:364-370
21. Soriano SG, Anand KJ (2005) Anesthetics and brain toxicity. Curr Opin Anaesthesiol 18:293-297
22. Sola A, Wen TC, Hamrick SE, Ferriero DM (2005) Potential for protection and repair following injury to the developing brain: a role for erythropoietin? Pediatr Res 57:110R-117R
23. Chong ZZ, Lin SH, Kang JQ, Maiese K (2003) Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8. J Neurosci Res 71:659-669
24. Siren AL, Fratelli M, Brines M et al (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 98:4044-4049
25. Wu Y, Shang Y, Sun S, Liang H, Liu R (2007) Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3beta/caspase-3 mediated signaling pathway. Apoptosis 12:1365-1375
26. Sakanaka M, Wen TC, Matsuda S et al (1998) In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA 95:4635-4640
27. Weishaupt JH, Rohde G, Polking E, Siren AL, Ehrenreich H, Bahr M (2004) Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Invest Ophthalmol Vis Sci 45:1514-1522
28. Kennedy SG, Wagner AJ, Conzen SD et al (1997) The PI3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev 11:701-713
29. Toker A (2000) Protein kinases as mediators of phosphoinositide 3-kinase signaling. Mol Pharmacol 57:652-658
30. Sutton G, Chandler LJ (2002) Activity-dependent NMDA receptor-mediated activation of protein kinase B/Akt in cortical neuronal cultures. J Neurochem 82:1097-1105
31. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789
32. Li M, Wang X, Meintzer MK, Laessig T, Birnbaum MJ, Heidenreich KA (2000) Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta. Mol Cell Biol 20:9356-9363
33. Somervaille TC, Linch DC, Khwaja A (2001) Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax. Blood 98:1374-1381